← Back to Search

Immulina Biomarker Identification for Supplement Intake Verification

N/A
Waitlist Available
Led By Gailen D Marshall, Jr., MD, PhD
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 7 hour period
Awards & highlights

Study Summary

This trial is testing if a natural dietary supplement can be used to help verify if a person has ingested it or not.

Who is the study for?
This trial is for healthy men and women aged 18-50 who can have children but use birth control, or women past menopause. It's not for those with serious acute illnesses, on recurring meds for chronic conditions, or pregnant/nursing females.Check my eligibility
What is being tested?
The study is testing Immulina™, a natural dietary supplement. Researchers are looking to identify markers in blood and/or urine that could confirm if someone has taken Immulina™ by comparing samples before and after consumption.See study design
What are the potential side effects?
Since this trial involves a dietary supplement (Immulina™), specific side effects aren't listed. However, as with any supplement, there may be potential risks of allergic reactions or gastrointestinal discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You must be in good health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 7 hour period
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 7 hour period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
5'-methylsulfinyladenosine (MSA), ug/mL
Sulfoquinovose (SQ), ug/mL
gamma-linolenic acid (GLA), ug/mL
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Immulina Dietary SupplementationExperimental Treatment1 Intervention
Immulina Dietary Supplementation (200 mg per capsule) 4-200 mg capsules given by mouth once on the only study visit day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immulina
2013
N/A
~50

Find a Location

Who is running the clinical trial?

University of Mississippi Medical CenterLead Sponsor
171 Previous Clinical Trials
194,995 Total Patients Enrolled
University of Mississippi National Center for Natural Products ResearchUNKNOWN
National Center for Complementary and Integrative Health (NCCIH)NIH
827 Previous Clinical Trials
668,724 Total Patients Enrolled

Media Library

Immulina Dietary Supplementation Clinical Trial Eligibility Overview. Trial Name: NCT05556967 — N/A
Patient Adherence Research Study Groups: Immulina Dietary Supplementation
Patient Adherence Clinical Trial 2023: Immulina Dietary Supplementation Highlights & Side Effects. Trial Name: NCT05556967 — N/A
Immulina Dietary Supplementation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05556967 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile meet the predetermined criteria to partake in this research?

"This clinical trial is admitting 20 people aged 18-50 who have adherence, patient. Additionally, the accepted applicants must meet several other requirements: gender (male or female), use of contraception if applicable, and overall good health."

Answered by AI

Is this research program open to people of a younger age?

"This medical trial only seeks patients aged 18 to 50, whereas other research projects in the same field are recruiting those below 18 and above 65. Specifically, 4 studies cater to younger individuals while 10 focus on senior citizens."

Answered by AI

Are there any open enrolment slots left in this research?

"By referencing clinicaltrials.gov, it can be determined that this study is not currently recruiting patients; the trial was created on October 1st 2022 and updated lastly on September 28th 2022. Even so, there are 14 alternative trials actively seeking participants presently."

Answered by AI
~13 spots leftby Mar 2025